NCT04113317View on ClinicalTrials.gov

Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Liver CirrhosisSevere MalnutritionPELDUndernutrition
Interventions
DRUG

G-CSF (Filgrastim)

Contains 0,59 mg of acetate, 0,04 mg of polysorbate 80, 0,035 mg of sodium, 50 mg of sorbitol

Trial Locations (1)

16424

Fakultas Kedokteran Universitas Indonesia, Jakarta

All Listed Sponsors
collaborator

Dr Cipto Mangunkusumo General Hospital

OTHER

lead

Fakultas Kedokteran Universitas Indonesia

OTHER

NCT04113317 - Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation | Biotech Hunter | Biotech Hunter